Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Topical glycopyrrolate 2% vs aluminum chlorohydrate 15% for axillary antiperspirant efficacy
2012-002807-17Phase 2Completed
- Sponsor
- L'Oréal Research & Innovation
- Start
- Jul 2012
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of glycopyrronium in axillary hyperhidrosis (2 arms), sponsored by L'Oréal Research & Innovation. Primary endpoint: Primary antiperspirant efficacy. Started Jul 2012; status: completed.
02
Drugs
glycopyrronium
03
Conditions
axillary hyperhidrosis
Beyond the preview
Go deeper on 2012-002807-17.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2012-002807-17.